Abstract
A series of new benzimidazole derivatives were designed and synthesized. Their chemical structures were testified by 1H NMR, infrared spectroscopy (IR), mass spectrography (MS), and elemental analysis. Their potent antiviral properties indicated the prospect of new drugs. Compound 13, 16, 18, 19, 21, 22, and 23 were identified as novel antivirus with much better selective activity and inhibitory activity than the comparable ribavirin against Coxsackie virus B3 in VERO cells.
Similar content being viewed by others
References
Cheng J, Xie J T, Luo X J. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives. Bioorg Med Chem Lett, 2005, 15: 267–269
Kristjan G, Richard S P, Aurora R L D. Preparation of (quinolinylaminoalkyl)-benzimidazole derivatives as chemokine receptor ligands with anti-HIV activity. WO2006023400
White A W, Almassy T, Calvert A H, Crutin N J, Griffin R J, Hostomsky Z, Maegley K, Newell D R, Srinivasan S, Golding B T. Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADPribose) polymerase. J Med Chem, 2000, 43: 4084–4097
Garuti L, Roberti M, Cermelli C. Synthesis and antiviral activity of some N-(benzenesulphonyl)-benzimidazoles. Bioorg Med Chem Lett, 1999, 9: 2525–2530
Garuti L, Roberti M, Clercq E D. Synthesis and antiviral/antiproliferative activity of some N-sulphonyl-benzimidazoles. Bioorg Med Chem Lett, 2002, 12: 2707–2710
Gilbert B E, Knight V. Biochemistry and clinical applications of ribavirin. Agents Chemother, 1986, 30: 201–205
Chapman E, Stephen H J. Preparation of phthalamic acids and their conversion into anthranilic acids. Chem Soc, 1925, 127: 1791–1797
Barkalow J H, Breting J, Gaede B J, Haight A R, Henry R, Kotecki B, Mei J, Pearl K B, Tedrow J S, Viswanath S K. Process Development for ABT-472, a Benzimidazole PARP Inhibitor. Organic Process Research and Development, 2007, 11: 693–698
William A D, Gordon W R, Bruce C B. Potential antitumor agents. 59. Structure-activity relationships for 2-phenylbenzimidazole-4-carboxamides, a new class of “minimal” DNA-intercalating agents which may not act via topoisomerase II. J Med Chem, 1990, 33: 814–819
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luo, X., Zhang, Z., Yang, Y. et al. Design, synthesis, and antiviral properties of 2-aryl-1H-benzimidazole-4-carboxamide derivatives. Front. Chem. Eng. China 3, 305–309 (2009). https://doi.org/10.1007/s11705-009-0021-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11705-009-0021-z